France Reimbursement Profile

Posted 20 September 2017 By Jenifer Ehreth, MHA, PhD

placeholder+image This profile summarizes the reimbursement process, presents key stakeholders in France and highlights complexities to be considered early in the development process.

Share this article:

Categories: Biologics and biotechnology, Drugs, Medical Devices, Reimbursement, Features, Europe

Tags: ANSM, ACAM, CEESP, CEPS, Reimbursement, France

Regulatory Exchange: Latest Updates From the Community